Comparison of filgrastim, pegfilgrastim, and lipegfilgrastim added to chemotherapy for mobilization of CD34+cells in non‐Hodgkin lymphoma patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparison of filgrastim, pegfilgrastim, and lipegfilgrastim added to chemotherapy for mobilization of CD34+cells in non‐Hodgkin lymphoma patients

Published:2018-11-19 Issue:1 Volume:59 Page:325-334
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Partanen A.¹²,Valtola J.¹,Ropponen A.³,Kuitunen H.⁴,Kuittinen O.⁴,Vasala K.⁵,Ågren L.⁶,Penttilä K.⁷⁸,Keskinen L.⁹,Pyörälä M.¹,Nousiainen T.¹,Selander T.¹⁰,Mäntymaa P.¹¹,Pelkonen J.³¹¹,Varmavuo V.¹²,Jantunen E.¹⁶²

Affiliation:

1. Department of MedicineKuopio University Hospital Kuopio Finland

2. Department of Clinical MedicineUniversity of Eastern Finland Kuopio Finland

3. Department of Clinical MicrobiologyUniversity of Eastern Finland Kuopio Finland

4. Department of OncologyOulu University Hospital Oulu Finland

5. Department of OncologyCentral Hospital of Central Finland Jyväskylä Finland

6. Siunsote‐ Hospital District of North Karelia Joensuu Finland

7. Department of MedicineCentral Hospital of Savonlinna Savonlinna Finland

8. The Finnish Medicines Agency Kuopio Finland

9. Department of OncologyTampere University Hospital Tampere Finland

10. Science Service CenterKuopio University Hospital Kuopio Finland

11. Eastern Finland Laboratory Centre Kuopio Finland

12. Department of MedicineKymenlaakso Central Hospital Kotka Finland

Funder

Sanofi

Suomen Kulttuurirahasto

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/trf.14993

Reference46 articles.

1. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009

2. The Evolving Role of Stem Cell Transplants in Lymphomas

3. Is the use of unrelated donor transplantation leveling off in Europe? The 2016 European Society for Blood and Marrow Transplant activity survey report

4. Lipegfilgrastim in the management of chemotherapy‐induced neutropenia of cancer patients;Guariglia R;Biologics,2016

5. Pegfilgrastim

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel PEGylated form of granulocyte colony-stimulating factor, mecapegfilgrastim, for peripheral blood stem cell mobilization in patients with hematologic malignancies;BMC Cancer;2023-07-24

2. Long-acting granulocyte colony-stimulating factor pegfilgrastim (lipegfilgrastim) for stem cell mobilization in multiple myeloma patients undergoing autologous stem cell transplantation;International Journal of Hematology;2021-07-02

3. Efficacy and Safety of Lipegfilgrastim in Lung Cancer Patients Receiving Myelosuppressive Chemotherapy in a Real-World Setting: Results of an Analysis of Pooled Data from Two Non-Interventional European Studies;Oncology Research and Treatment;2021-01-21

4. Autologous stem cell transplantation in peripheral T-cell lymphoma: better mobilization of blood CD34+ cells is associated with improved survival;Leukemia & Lymphoma;2020-07-10

5. A prospective comparison of pegfilgrastim and lipegfilgrastim combined with chemotherapy in the mobilization of CD34 + cells in NHL patients;Journal of Clinical Apheresis;2020-04-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3